GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427104. A total of 60 filers reported holding GENOCEA BIOSCIENCES INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,917,000 | +3.0% | 479,000 | -30.3% | 0.11% | -2.6% |
| Q4 2016 | $2,831,000 | -19.6% | 687,257 | 0.0% | 0.12% | -29.3% |
| Q3 2016 | $3,519,000 | +24.9% | 687,257 | 0.0% | 0.16% | +47.7% |
| Q2 2016 | $2,818,000 | -53.8% | 687,257 | -12.7% | 0.11% | -57.1% |
| Q1 2016 | $6,093,000 | +38.1% | 787,257 | -6.0% | 0.26% | +44.7% |
| Q4 2015 | $4,412,000 | +28.5% | 837,257 | +67.0% | 0.18% | +34.6% |
| Q3 2015 | $3,434,000 | -55.7% | 501,257 | -11.2% | 0.13% | -48.4% |
| Q2 2015 | $7,747,000 | -22.6% | 564,257 | -33.2% | 0.26% | -20.4% |
| Q1 2015 | $10,013,000 | +136.7% | 844,257 | +39.7% | 0.32% | +113.2% |
| Q4 2014 | $4,230,000 | -15.7% | 604,257 | +9.0% | 0.15% | -16.9% |
| Q3 2014 | $5,016,000 | -44.6% | 554,257 | +14.7% | 0.18% | -49.7% |
| Q2 2014 | $9,060,000 | -24.5% | 483,219 | -26.8% | 0.36% | -25.7% |
| Q1 2014 | $12,005,000 | – | 659,983 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 25,000,000 | $19,500,000 | 0.84% |
| Polaris Venture Management Co. V, L.L.C. | 1,968,606 | $1,535,000 | 0.77% |
| Vivo Capital, LLC | 8,180,000 | $6,378,000 | 0.64% |
| Ghost Tree Capital, LLC | 3,525,000 | $2,748,000 | 0.58% |
| BVF INC/IL | 5,265,000 | $4,105,000 | 0.36% |
| Birchview Capital, LP | 189,000 | $147,000 | 0.10% |
| DRW Securities, LLC | 469,343 | $366,000 | 0.02% |
| Fosun International Ltd | 403,678 | $323,000 | 0.02% |
| Alyeska Investment Group, L.P. | 1,500,000 | $1,170,000 | 0.01% |
| AlphaMark Advisors, LLC | 40,064 | $31,000 | 0.01% |